Paper7957769
The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
Himori N and 1 other. Experientia, 1994. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice. Papers, record 7957769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7957769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 1-Methyl-4-phenylpyridinium | Major topic |
| Benserazide | Major topic |
| Benzophenones | Major topic |
| Catalepsy | Major topic |
| Catechol O-Methyltransferase Inhibitors | Major topic |
| Levodopa | Major topic |
| Animals | |
| Drug Combinations | |
| Drug Synergism | |
| Haloperidol | |
| Kinetics | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Nitrophenols | |
| Tolcapone | |
| Tyrosine |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 878846 | Does O-methyl-dopa play a role in levodopa-induced dyskinesias? | Acta Neurol Scand | 1977 | https://conductscience.org/library/papers/878846 | PubMed |
| 2 | 2990509 | [Effects of S-adenosyl-L-methionine on experimental cerebral ischemia]. | No To Shinkei | 1985 | https://conductscience.org/library/papers/2990509 | PubMed |
| 3 | 2292704 | Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. | J Neurol Neurosurg Psychiatry | 1990 | https://conductscience.org/library/papers/2292704 | PubMed |
| 4 | 1977408 | Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. | J Neural Transm Park Dis Dement Sect | 1990 | https://conductscience.org/library/papers/1977408 | PubMed |
| 5 | 5669881 | Accurate freehand injection into the lateral brain ventricle of the conscious mouse. | J Appl Physiol | 1968 | https://conductscience.org/library/papers/5669881 | PubMed |
| 6 | 1473553 | Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged rats. | Eur J Pharmacol | 1992 | https://conductscience.org/library/papers/1473553 | PubMed |
| 7 | 1933685 | New approaches to the treatment of age-related brain disorders. | Can J Neurol Sci | 1991 | https://conductscience.org/library/papers/1933685 | PubMed |
| 8 | 1143006 | 3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier. | Life Sci | 1975 | https://conductscience.org/library/papers/1143006 | PubMed |
| 9 | 156544 | Increased Ca2+ -ATPase activity associated with methylation of phospholipids in human erythrocytes. | Biochem Biophys Res Commun | 1979 | https://conductscience.org/library/papers/156544 | PubMed |
| 10 | 7201586 | 3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway. | Neurology | 1982 | https://conductscience.org/library/papers/7201586 | PubMed |
| 11 | 2792191 | Effect of S-adenosyl-L-methionine on impairment of working memory induced in rats by cerebral ischemia and scopolamine. | Eur J Pharmacol | 1989 | https://conductscience.org/library/papers/2792191 | PubMed |
| 12 | 8420203 | Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings. | Adv Neurol | 1993 | https://conductscience.org/library/papers/8420203 | PubMed |
| 13 | 6367973 | Pharmacokinetics of levodopa. | Clin Neuropharmacol | 1984 | https://conductscience.org/library/papers/6367973 | PubMed |
| 14 | 8177909 | 3-O-methyldopa attenuates the effects of Madopar on the haloperidol-induced cataleptic behavior and the locomotor activity in the mouse. | Pharmacology | 1994 | https://conductscience.org/library/papers/8177909 | PubMed |
| 15 | 2950730 | Pharmacokinetics of L-dopa in patients with Parkinson's disease. | Adv Neurol | 1987 | https://conductscience.org/library/papers/2950730 | PubMed |
| 16 | 7398195 | Catechol-O-methyltransferase activity: a determinant of levodopa response. | Clin Pharmacol Ther | 1980 | https://conductscience.org/library/papers/7398195 | PubMed |
| 17 | 6328152 | Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. | Life Sci | 1984 | https://conductscience.org/library/papers/6328152 | PubMed |
| 18 | 2089102 | Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues. | J Neural Transm Suppl | 1990 | https://conductscience.org/library/papers/2089102 | PubMed |
| 19 | 724827 | Effect of S-adenosyl-L-methionine on serotonin metabolism in rat brain. | Prog Neuropsychopharmacol | 1978 | https://conductscience.org/library/papers/724827 | PubMed |
| 20 | 2196554 | Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. | Pharmacol Toxicol | 1990 | https://conductscience.org/library/papers/2196554 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 23248072 | Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor. | Clin Pharmacokinet | 2013 | https://conductscience.org/library/papers/23248072 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7957769
GET https://conductscience.org/api/papers/v1/7957769/references?page=2